Evolvere BioSciences
Oxford
About Evolvere BioSciences
Evolvere BioSciences develops next-generation antibiotics using AI-driven co-evolutionary models to outpace bacterial resistance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $500.0K
- Funding stage: Seed
- Last round: Pre-Seed (Sep 2024)
- Website: evolverebiosciences.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Bioinformatics, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/evolvere-biosciences-52595 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.